Injection volume and parenteral routes

Absorption is the step that separates the four parenteral routes. A drug given intravenously is placed directly into the bloodstream, so there is no absorption phase at all: bioavailability is 100 %, onset is immediate, and the entire dose is active at once. The other three routes deposit the drug into tissue and rely on capillaries to carry it away, so the speed of onset depends on blood flow at the site. Muscle is richly perfused, which is why an intramuscular injection acts within minutes; the deltoid, the ventrogluteal region and the vastus lateralis are chosen because they are thick, well supplied and away from major nerves and vessels. Subcutaneous tissue has less blood flow, so absorption is slower and steadier, which is exactly what a drug such as insulin or heparin needs. The dermis used for an intradermal injection has almost no absorbing surface; it is chosen to place a tiny volume where the immune system can see it, as in a tuberculin (Mantoux) test. These differences set practical limits. An adult intramuscular site usually accepts 1–3 mL and no more; a subcutaneous site accepts about 1 mL, rarely 2 mL; an intradermal injection is measured in tenths of a millilitre, typically 0.1 mL. Needle angle follows the depth: 90° for muscle, 45–90° for subcutaneous, 10–15° for intradermal with the bevel up. Irritant drugs given intramuscularly may use the z-track method, in which the skin is pulled aside before the needle is inserted so that the track seals behind the drug. The intravenous route is the least forgiving of all: a dose ten times too large cannot be slowed once it is in the vein, and the same route that gives the fastest relief can also give the fastest reaction.

A vial is a closed container sealed with a rubber septum, and almost everything you need is printed on its label — but the label can state its strength in more than one way, and each way hides a different trap. A single-dose vial is meant for one patient and contains no preservative; a multi-dose vial carries a preservative so that several withdrawals can be made, and it must be dated when first opened and discarded by its beyond-use date. Manufacturers routinely overfill a vial. A vial labelled 10 mL may contain 10.5 mL of liquid, and that extra half-millilitre is not an extra dose: never use the surplus to top up a volume that came out short, and never assume that the whole contents are the ordered amount. A powdered vial has no strength at all until it is reconstituted. The label names the diluent — usually sterile water or normal saline — and the total volume after mixing, and sometimes it specifies the diluent because the wrong one will inactivate the drug. The strength you then use is the total drug, for example 500 mg, divided by that final volume, for example 2.4 mL, which is why Q is 2.4 mL and not the 2 mL of liquid you injected. Read every label for the unit as well as the number: micrograms and milligrams differ by a factor of 1,000, and a vial labelled in micrograms cannot be poured into a milligram calculation without converting first. A proportion cross-check catches most slips: if H ÷ Q is the strength per millilitre, then D ÷ X must equal the same figure. For 75 mg drawn as 1.5 mL from a 100 mg/2 mL vial, 100 ÷ 2 = 50 mg/mL and 75 ÷ 1.5 = 50 mg/mL, so the two agree. Before use, inspect the solution: cloudiness, particles or a changed colour mean the vial is discarded, not shaken and injected.

Before any injection is given, the calculated volume must pass three practical tests, and a beginner should run them in order. First, capacity: does the volume fit the syringe you have, and is that syringe the right size? A 0.35 mL dose belongs in a 1 mL syringe graduated in hundredths, not in a 10 mL syringe where the whole dose disappears between two marks. Second, route limit: the safe volume for a site is set by the tissue, not by the order, and a volume that exceeds it must not be forced. Third, measurability: can the volume be read accurately at the graduations on the syringe, or does it fall awkwardly between two marks? When any test fails, the correct action is escalation, not improvisation. Escalation here means contacting the prescriber or the pharmacist with a precise message: the drug, the ordered dose, the strength on hand, the route, the volume your calculation produced, and the reason it cannot be given as written. The pharmacist may dispense a more concentrated presentation, which is the cleanest solution, because concentration is the lever that controls volume for a fixed dose. If a solution contains C mg per mL, the volume needed for a dose D is V = D ÷ C. A 300 mg subcutaneous dose is 3 mL of a 100 mg/mL vial but only 1 mL of a 300 mg/mL vial: same drug, same dose, one third of the volume. The lever works only when a suitable product exists; you cannot invent a concentration by discarding part of a vial. Two practices are forbidden without a new order. Never round a volume to the nearest graduation just to make it fit — 0.35 mL is not 0.4 mL unless an explicit policy says so for that drug. Never split one ordered injection into two sites, or change the route, on your own judgement, however reasonable it looks. Document the query, the person you spoke to, the reply and the time; an injection that was questioned and clarified is a safety success, not a delay.

An injection is irreversible, and the preparation step is where most preventable risk sits. Once the plunger is pressed, the drug is in the patient; there is no tablet to withhold and no stomach to empty. That single fact is the reason for two routines that accompany every parenteral dose. The first is aseptic non-touch technique, usually shortened to ANTT. Its purpose is to keep microorganisms and particles out of the solution and out of the tissues. The nurse performs hand hygiene, cleans the work surface, swabs the rubber septum of the vial with alcohol and lets it dry completely — a wet septum carries alcohol into the tissue and stings — and never allows the needle, the hub or the tip of the syringe to touch anything that is not sterile. A new, sterile needle is used for the injection itself, and every needle goes straight into a puncture-resistant sharps container. Single-use items are used once. The second routine is the independent double-check, which is required for high-alert medicines such as insulin, heparin, opioids and concentrated potassium. “Independent” is the operative word: two nurses each work the calculation from the original order and the vial label without looking at the other’s figure, and only then compare their answers. Reading your own answer aloud while a colleague nods is not a double-check; it is a single check performed twice. The same discipline applies to the drug, the route, the time, the patient’s identity and the expiry date. Before a high-risk injection, confirm that resuscitation equipment and the antidote or reversal agent for that drug are within reach, because a reaction to a parenteral dose can begin within seconds. Anaphylaxis after an injection is treated with adrenaline, oxygen and fluids, and the nurse who prepared the dose is often the first to recognise the signs — swelling, wheeze, falling blood pressure — and the one who calls for help.